We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Effect of Colchicine on Platelet-Platelet and Platelet-Leukocyte Interactions: a Pilot Study in Healthy Subjects.
- Authors
Shah, Binita; Allen, Nicole; Harchandani, Bhisham; Pillinger, Michael; Katz, Stuart; Sedlis, Steven; Echagarruga, Christina; Samuels, Svetlana; Morina, Pajazit; Singh, Prabhjot; Karotkin, Liza; Berger, Jeffrey
- Abstract
The cardioprotective mechanisms of colchicine in patients with stable ischemic heart disease remain uncertain. We tested varying concentrations of colchicine on platelet activity in vitro and a clinically relevant 1.8-mg oral loading dose administered over 1 h in 10 healthy subjects. Data are shown as median [interquartile range]. Colchicine addition in vitro decreased light transmission platelet aggregation only at supratherapeutic concentrations but decreased monocyte- (MPA) and neutrophil-platelet aggregation (NPA) at therapeutic concentrations. Administration of 1.8 mg colchicine to healthy subjects had no significant effect on light transmission platelet aggregation but decreased the extent of MPA (28 % [22-57] to 22 % [19-31], p = 0.05) and NPA (19 % [16-59] to 15 % [11-30], p = 0.01), platelet surface expression of PAC-1 (370 mean fluorescence intensity (MFI) [328-555] to 333 MFI [232-407], p = 0.02) and P-selectin (351 MFI [269-492] to 279 [226-364], p = 0.03), and platelet adhesion to collagen (10.2 % [2.5-32.6] to 2.0 % [0.2-9.5], p = 0.09) 2 h post-administration. Thus, in clinically relevant concentrations, colchicine decreases expression of surface markers of platelet activity and inhibits leukocyte-platelet aggregation but does not inhibit homotypic platelet aggregation.
- Subjects
COLCHICINE; DRUG efficacy; BLOOD platelets; LEUCOCYTES; CELL communication; THERAPEUTICS
- Publication
Inflammation, 2016, Vol 39, Issue 1, p182
- ISSN
0360-3997
- Publication type
Article
- DOI
10.1007/s10753-015-0237-7